Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Debt (2021 - 2024)

Historic Total Debt for Biofrontera (BFRI) over the last 4 years, with Q2 2024 value amounting to $296000.0.

  • Biofrontera's Total Debt changed N/A to $296000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $296000.0, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2023, which is 4376.26% down from last year.
  • According to the latest figures from Q2 2024, Biofrontera's Total Debt is $296000.0.
  • Over the past 5 years, Biofrontera's Total Debt peaked at $7.2 million during Q3 2023, and registered a low of $296000.0 during Q2 2024.
  • Its 4-year average for Total Debt is $4.3 million, with a median of $3.6 million in 2021.
  • Per our database at Business Quant, Biofrontera's Total Debt surged by 12242.44% in 2023 and then tumbled by 6651.02% in 2024.
  • Over the past 4 years, Biofrontera's Total Debt (Quarter) stood at $3.2 million in 2021, then surged by 114.13% to $6.9 million in 2022, then crashed by 43.76% to $3.9 million in 2023, then tumbled by 92.42% to $296000.0 in 2024.
  • Its last three reported values are $296000.0 in Q2 2024, $2.4 million for Q1 2024, and $3.9 million during Q4 2023.